S. 799 would authorize the Department of Health and Human Services (HHS) to plan and coordinate activities related to prenatal opioid abuse and neonatal abstinence syndrome (NAS). In addition, this bill would require HHS to study and recommend treatments and would allow HHS to provide technical assistance to states in collecting data for prenatal opioid abuse and NAS.
CBO expects that implementing S. 799 would cost $27 million over the 2016-2020 period, assuming appropriation of the necessary amounts. Enacting S. 799 would not affect direct spending or revenues; therefore, pay-as-you-go procedures do not apply.
S. 799 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.